The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

AUTOR(ES)

Stearns-Kurosawa, D J

RESUMO

Protein C activation on the surface of the endothelium is critical to the negative regulation of blood coagulation. We now demonstrate that monoclonal antibodies that block protein C binding to the endothelial cell protein C receptor (EPCR) reduce protein C activation rates by the thrombin-thrombomodulin complex on endothelium, but that antibodies that bind to EPCR without blocking protein C binding have no effect. The kinetic result of blocking the EPCR-protein C interaction is an increased apparent Km for the activation without altering the affinity of thrombin for thrombomodulin. Activation rates of the protein C derivative lacking the gamma-carboxyglutamic acid domain, which is required for binding to EPCR, are not altered by the anti-EPCR antibodies. These data indicate that the protein C activation complex involves protein C, thrombin, thrombomodulin, and EPCR. These observations open new questions about the control of coagulation reactions on vascular endothelium.

Documentos Relacionados

• Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.
• Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation.
• Activation of signalling by the activin receptor complex.
• Anti-immunoglobulin augments the B-cell antigen-presentation function independently of internalization of receptor-antigen complex.
• Phosphorylation of the ETS-2 protein: regulation by the T-cell antigen receptor-CD3 complex.